Clinical Benefits of Leukodepleted Blood Products
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
1995.
|
| Edición: | 1st ed. 1995. |
| Colección: | Medical Intelligence Unit
|
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-3-662-26538-3 |
Tabla de Contenidos:
- 1. Introduction
- 2. Methods of Leukodepletion
- 3. Enumeration of Low White Cells
- 4. Mechanisms of Leukodepletion by Filtration
- 5. Role of Contaminating White Blood Cells in the Storage Lesions of Red Cells and Platelets
- 6. Leukodepletion to Prevent Transfusion Reactions: Effects on Cytokines and Other Biologic Response Modifiers
- 7. Leukodepletion and Alloimmunization
- 8. Role of Donor Leukocytes and Leukodepletion in Transfusion-Associated Viral Infections
- 9. Leukocyte Depletion and Transfusion-Induced Immunomodulation
- 10. The Role of Leukocyte Depletion in Prevention of Transfusion-Related Acute Lung Injury
- 11. The Role of Leukocyte Depletion in the Prevention of Reperfusion Injury Associated with Open Heart Surgery
- 12. The Use of Leukodepleted Blood Components for Neonates and Infants
- 13. Leukocyte Depleted Blood Transfusion in Hematopoietic Stem Cell Reconstitution Therapy
- 14. Cost-Effectiveness of Leukodepletion.